Dallah Healthcare Company Overview
- Year Founded
-
1987
- Status
-
Public
- Stock Symbol
-
4004
- Investments
-
11
- Share Price
-
$15.29
- (As of Thursday Closing)
Dallah Healthcare Company General Information
Description
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing, and maintaining the healthcare entities, wholesale medicines, and retail of medical and surgical equipment, prosthetics, and devices for the disabled, hospital equipment, and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Facilities and Pharmacies, and Distribution of Pharmaceutical Products. The company generates the majority of its revenue from the Medical Facilities and Pharmacies segment.
Contact Information
Website
www.dallahhealth.comCorporate Office
- King Fahad Road
- Nakheel
- Riyadh 12381
- Saudi Arabia
Corporate Office
- King Fahad Road
- Nakheel
- Riyadh 12381
- Saudi Arabia
Dallah Healthcare Company Stock Performance
As of 12-Nov-2026, Dallah Healthcare Company’s stock price is $15.29. Its current market cap is $1.86B with 122M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $15.29 | $15.50 | $14.24 - $33.27 | $1.86B | 122M | 171K | $0.96 |
Dallah Healthcare Company Financials Summary
As of 30-Jun-2026, Dallah Healthcare Company has a trailing 12-month revenue of $1.14B.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 3,875,946 | 4,310,838 | 4,446,282 | 5,000,956 |
| Revenue | 1,140,609 | 1,083,412 | 852,392 | 782,550 |
| EBITDA | 232,747 | 245,568 | 199,575 | 167,543 |
| Net Income | 117,698 | 143,394 | 125,291 | 95,761 |
| Total Assets | 2,476,633 | 2,433,090 | 1,757,675 | 1,632,093 |
| Total Debt | 1,094,661 | 1,047,785 | 537,801 | 515,910 |
Dallah Healthcare Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Dallah Healthcare Company Comparisons
Industry
Financing
Details
Dallah Healthcare Company Competitors (2)
One of Dallah Healthcare Company’s 2 competitors is Mouwasat Medical Services, a Formerly PE-Backed company based in Dammam, Saudi Arabia.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mouwasat Medical Services | Formerly PE-Backed | Dammam, Saudi Arabia | ||||
| Dr Sulaiman Al Habib | Corporation | Riyadh, Saudi Arabia |
Dallah Healthcare Company Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Dallah Healthcare Company Investments & Acquisitions (11)
Dallah Healthcare Company’s most recent deal was a Secondary Transaction - Private with Al-Ahsa Medical Services for . The deal was made on 23-Apr-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Al-Ahsa Medical Services | 23-Apr-2026 | Secondary Transaction - Private | Hospitals/Inpatient Services | ||
| Kingdom Hospital and Consulting Clinics | 28-Dec-2025 | Secondary Transaction - Private | Hospitals/Inpatient Services | ||
| Al-Ahsa Medical Services | 06-Apr-2025 | Merger/Acquisition | Hospitals/Inpatient Services | ||
| NMC As- Salama Medical Hospital | 20-Aug-2024 | Merger/Acquisition | Hospitals/Inpatient Services | ||
| International Medical Center (Saudi Arabia) | 24-Nov-2022 | Secondary Transaction - Private | Hospitals/Inpatient Services |
Dallah Healthcare Company ESG
Risk Overview
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Facilities
Subindustry
Rank
Percentile
Dallah Healthcare Company Exits (1)
Dallah Healthcare Company’s most recent exit was on 01-Apr-2015 from Dr. Mohammed bin Rashed Al-Faqih & Partners. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Dr. Mohammed bin Rashed Al-Faqih & Partners | 01-Apr-2015 | Completed |
|
Dallah Healthcare Company Affiliates
Subsidiaries (5)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Al-Ahsa Medical Services | Al Hufuf, Saudi Arabia | 2002 | |
| Makkah Medical Center | Makkah, Saudi Arabia | 1990 | |
| Dr. Erfan and Bagedo General Hospital | Jeddah, Saudi Arabia | 1981 | |
| NMC As- Salama Medical Hospital | Al Khobar, Saudi Arabia | 1958 | |
| Kingdom Hospital and Consulting Clinics | Riyadh, Saudi Arabia |
Dallah Healthcare Company FAQs
-
When was Dallah Healthcare Company founded?
Dallah Healthcare Company was founded in 1987.
-
Where is Dallah Healthcare Company headquartered?
Dallah Healthcare Company is headquartered in Riyadh, Saudi Arabia.
-
What industry is Dallah Healthcare Company in?
Dallah Healthcare Company’s primary industry is Hospitals/Inpatient Services.
-
Is Dallah Healthcare Company a private or public company?
Dallah Healthcare Company is a Public company.
-
What is Dallah Healthcare Company’s stock symbol?
The ticker symbol for Dallah Healthcare Company is 4004.
-
What is the current stock price of Dallah Healthcare Company?
As of 12-Nov-2026 the stock price of Dallah Healthcare Company is $15.29.
-
What is the current market cap of Dallah Healthcare Company?
The current market capitalization of Dallah Healthcare Company is $1.86B.
-
What is Dallah Healthcare Company’s current revenue?
The trailing twelve month revenue for Dallah Healthcare Company is $1.14B.
-
Who are Dallah Healthcare Company’s competitors?
Mouwasat Medical Services and Dr Sulaiman Al Habib are competitors of Dallah Healthcare Company.
-
What is Dallah Healthcare Company’s annual earnings per share (EPS)?
Dallah Healthcare Company’s EPS for 12 months was $0.96.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process